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Bilateral ovarian metastasis from invasive squamous cell carcinoma of the cervix is a rare phenomenon with very
few clinically significant cases described in the literature. Ovarian metastases when present are usually seen in
association with bulky, advanced cervical squamous cell carcinomas with extensive involvement of the uterus.
We describe a 48 year old woman with clinically normal cervix whose hysterectomy and bilateral salpingo-oophorectomy
performed for abnormal uterine bleeding, demonstrated high grade squamous intraepithelial lesion, moderately
differentiated squamous cell carcinoma involving the deeper stroma of the uterus and bilateral ovarian metastases.
Gross examination of the cervical canal and the uterine cavity did not show tumor while well circumscribed pearly
white metastatic deposits were distinguished within the parenchyma of both the ovaries. Microscopy ascertained
high grade squamous intraepithelial lesion with malignant cells invading the deeper cervical stroma and disseminating
further as lymphovascular tumor emboli within the myometrium of the corpus uteri without involving the
endometrium. Both the fallopian tubes exhibited lymphovascular tumor emboli without epithelial involvement
while the parenchyma of both the ovaries showed metastatic deposits.
Although an isolated case of endophytic squamous cell carcinoma of the cervix with extensive lymphovascular
invasion of the corpus uteri, both the fallopian tubes and bilateral ovarian deposits without involving either the
endometrium or the tubal mucosa does not form a paradigm, this case brings to light the capricious behavior of
cervical squamous cell carcinoma.
Virtual Slides: The virtual slide(s) for this article can be found here: http://www.diagnosticpathology.diagnomx.
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Ovarian metastases from squamous cell carcinoma (SCC)
of the cervix are rare and reported in less than 1% of early
stage cervical SCC [1]. The risk increases with advanced le-
sions and in most of these cases the lesions are often bulky.
Nakanishi et al in their comparative study between SCC
and adenocarcinoma of the uterine cervix reported that
ovarian metastases were found in 1.3% and 6.3% of cases
respectively. The incidence in those with adenocarcinoma
was associated more closely with tumor size whereas it was
more associated with clinical stage in SCC [2].* Correspondence: drsirisha.g@fernandezhospital.com
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unless otherwise stated.We present a case of endophytic SCC of the cervix with
extensive lymphovascular tumor emboli disseminating
within the stroma of the corpus uteri, the tuba uterina and
perpetuating as parenchymal deposits within both the
ovaries without involving either the endometrium or the
tubal mucosa. This, to the best of our knowledge has not
been published before.Case presentation
Case report
A 48 year old P4L4 visited the Gynecology outpatient de-
partment with chief complaints of heavy vaginal bleeding
for 10 days following an eight-month period of amenor-
rhea. Progestin therapy was initiated as there was no relief
of menorrhagia with tranexamic acid. Apart from severeLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sult, there was no other significant contributory history.
General physical and breast examination was unremark-
able. The cervix and vagina appeared normal with no focal
lesions and bimanual palpation disclosed an enlarged
uterus corresponding to 14-16 weeks’ size. Ultrasonog-
raphy revealed a bulky uterus with thickened endomet-
rium. The ovaries were enlarged (right: 53 × 34 × 37 mm;
left: 42×32×29 mm) but had a normal echotexture. At
hysteroscopy, the endometrium appeared mildly hyper-
plastic and there was no abnormality in the cervical canal.
Papanicolaou smear was initially reported as negative for
intraepithelial lesions and malignancy (Figure 1a,b,c) while
a simultaneously performed endometrial biopsy showed
secretory endometrium, post ovulatory day 3 with con-
comitant exogenous hormone induced changes (Figure 1d).
There was no evidence of endometritis, granulomas,
hyperplasia, atypia or malignancy in the endometrial bi-
opsy. Despite the availability of alternative treatment
modalities such as oral progestins, endometrial ablation
and Mirena levonorgestrel-intrauterine system, the pa-
tient opted for the removal of uterus. Consequently,
total laparoscopic hysterectomy with bilateral salpingo-
oophorectomy was performed.
Pathologic findings
The uterus was received bisected (9.0 × 6.0 × 5.0 cm, 356.0
gm) with an essentially normal endometrial lining and
thickened myometrium (Figure 2a). The exocervix (1.5 ×
1.5 cm) had focally irregular mucosal surface. The endocer-
vix (2.5 cm in length) was unremarkable. Small nodules
varying in diameter from 0.5 to 1.0 cm were noticed nearFigure 1 Pap smear and endometrial biopsy. a, b & c: High grade squa
endometrium (hematoxylin and eosin 100 x).the fimbrial ends while the tubal lumina were patent with-
out mucosal thickening. The right ovary had a convoluted
external surface which upon sectioning demonstrated near
complete replacement of the ovarian parenchyma by a grey
white lesion (3.9 × 2.3 × 0.7 cm) (Figure 2b). There was no
hemorrhage or necrosis. The left ovary had a convoluted
external surface and the parenchyma showed two grey
white well demarcated lesions (2.0 × 1.0 cm and 1.0 ×
1.0 cm) and a single smooth walled cortical cyst (Figure 2c).
After overnight fixation in 10% formalin and processing, the
tissues were embedded in paraffin. Multiple 3 to 5 micron
sections were cut and stained with hematoxylin and eosin.
Immunohistochemical study was performed by Dako’s envi-
sion method.
Microscopically cervical intraepithelial neoplasia
grade 3 was detected over the surface epithelium while
the deeper stroma exhibited islands of moderately dif-
ferentiated SCC (Figure 3). The endometrium was weakly
proliferative, completely uninvolved by tumor. Both the
fallopian tubes showed hydrosalpinx and the lumina were
devoid of tumor deposits (Figure 4a). There was ubiqui-
tous presence of lymphovascular tumor emboli within the
cervical stroma, myometrium and the tunica muscularis
(Figure 4b). Both the ovaries showed well circumscribed
nodular tumor deposits of moderately differentiated SCC
(Figure 4c,d). Contiguous ovarian parenchyma showed
normal stroma, corpora albicantes and thick walled ves-
sels. The left ovary additionally showed a follicular cyst.
The endophytic cervical lesion, the lymphovascular
channels within the endomyometrium and the tubes,
and the ovarian lesions demonstrated strong positivity
to p63 and high molecular weight cytokeratin CK5/6mous intraepithelial lesion (Papanicolaou 400 x); d: Secretory
Figure 2 Macroscopy of uterus and bilateral ovaries. a: Bisected uterus; b & c: Cut surface right and left ovary
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7a,b). Squamous differentiation is characterized by strong
nuclear staining with p63 and cytoplasmic staining with
CK5/6, and the positive staining of these markers corrobo-
rated with the neoplastic foci seen on hematoxylin and
eosin sections. Significant negative markers included CK7/
CK20 (Figures 5c,d, 6c,d, 7c,d), leukocyte common antigen,
gross cystic disease fluid protein, CD117 and inhibin.
Morphology and IHC evaluation concluded that the bi-
lateral ovarian metastases, ubiquitous tumor emboli in the
lymphovascular channels of the fallopian tubes and endo-
myometrium, and the endophytic cervical lesion were all
squamous and originated in the exocervical epithelium.
Despite liberal sampling the mucosal involvement of the
endometrium or the tubes could not be demonstrated. A
review of the cervical cytology smears ascertained that
neoplastic cells had been misinterpreted as reactive endo-
cervical cells by a trainee neophyte pathologist.Figure 3 Cervical intraepithelial neoplasia (CIN) stained with hematox
b: CIN (400 x); c: Stromal invasion (200 x); d: Stromal invasion (400 x)Discussion
Metastatic tumors to the ovary account for approximately
10 – 15% of ovarian malignancies [3] with the majority of
the metastatic tumors arising from the genital tract. Cer-
vical cancer is a very rare cause of ovarian metastasis [4]
and the risk is more likely in advanced disease vis-à-vis
early stage cervical cancer [5]. Most of the advanced cases
described have bulky exophytic growths with extensive
corpus uteri involvement. Metastases to ovaries occur in
0.5% of cases of SCC and 1.7% of cases of adenocarcin-
oma, so ovarian preservation at the time of surgery may
incur a small risk of occult disease [5].
In a large autopsy series by Tabata et al [6] ovarian me-
tastases were found in 104 out of 597 (17.4%) cases of
SCC as opposed to 28.6% cases of adenocarcinoma while
Toki et al [7] reported ovarian metastasis in only one case
of 524 SCCs. Most of the ovarian metastases reported are
microscopic, unilateral, confined to ovarian parenchymaylin and eosin. a: CIN with cautery artefact in underlying tissue (20 x);
Figure 4 Microscopic images of metastases stained with hematoxylin and eosin. a: Left tubal stromal metastasis (20 x); b: Endomyometrial
tumor emboli (20 x); c: Left ovarian metastasis (20 x); d: Right ovarian metastasis (40 x).
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factors for ovarian metastasis include age, stage, non squa-
mous histology, unaffected peripheral stromal thickness
[12] and uterine corpus involvement [13].
Possible routes of spread to the ovary from cervical can-
cer include hematologic metastasis [14], or lymphatic
drainage and transtubal drainage [6] and involvement of
the corpus may potentiate these mechanisms. Reverse
transcriptase in situ polymerase chain reaction for human
papillomavirus ribonucleic acid is a reliable method toFigure 5 Immunohistochemical staining of endomyometrium. a: p63 p
(20 x); c: CK7 negativity (100 x); d: CK20 negativity (100 x)differentiate metastatic cervical carcinoma from either a
new primary tumor or a metastasis from another cancer
[15]. In the female genital tract, p63 is expressed in the
basal and parabasal layers of mature cervical, vaginal, and
vulval squamous epithelium, and is useful to establish the
diagnosis of cervical squamous cell carcinoma [16].
Endophytic cervical squamous cell carcinoma with
normal endocervical, endometrial and fallopian tube epi-
thelia, extensive lymphovascular invasion of the entire
genital tract and bilateral parenchymal involvement of theositivity (100 x); b: High molecular weight cytokeratin CK5/6 positivity
Figure 6 Immunohistochemical staining of right ovary. a: p63 positivity (100 x); b: High molecular weight cytokeratin CK5/6 positivity (100 x);
c: CK7 negativity (40 x); d: CK20 negativity (40 x).
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mors may appear normal speculoscopically and colposcopi-
cally. The growth occurs in the cervical canal with direct
infiltration into the wall causing diffuse enlargement and
hardening of the cervix. The mucosal surface may be cov-
ered by normal epithelium, and the underlying malignant
cells may escape detection by cytologic smear. These endo-
phytic tumors may produce a barrel-shaped cervix, which
has a diameter greater than 4 cm. Rectal examination can
be helpful in such cases to palpate the enlarged uterineFigure 7 Immunohistochemical staining of left ovary. a: p63 positivity
c: CK7 negativity (40 x); d: CK20 negativity (40 x)cervix and the role of MRI is usually complementary. Ac-
tual pathophysiological mechanisms leading to abnormal
bleeding in carcinoma cervix are poorly understood, but
are probably due to the presence and dilatation of abnormal
surface vessels on the lesion [17].
Since the ovaries in our case demonstrated solid tumor bi-
laterally, primary solid ovarian neoplasms such as Brenner
tumor, non cystic ovarian teratoma, dysgerminoma, granu-
losa cell tumor and lymphoma were excluded with the help
of IHC markers. Apart from these, ovarian endometrioid(100 x); b: High molecular weight cytokeratin CK5/6 positivity (100 x);
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demonstrates CK7 and epithelial membrane antigen positiv-
ity [18] was differentiated by negativity in our case. Endome-
trioid adenocarcinoma with squamous differentiation may
show keratin granulomas over the surface of the ovary and
if viable tumor cells are observed in the granulomas, these
lesions should be regarded as conventional metastatic foci
[19]. There were no keratin granulomas or peritoneal de-
posits in our case. Further the endophytic nature required
differentiation from mesonephric adenocarcinoma with sar-
comatous component [20]. Absence of sarcomatous compo-
nent in the cervical biopsy helped exclude this lesion. Non-
involvement of endometrium with invasive squamous cell
carcinoma, along with demonstration of secretory changes
and concomitant exogenous hormone induced features war-
ranted that a FIGO grade 1 endometrioid adenocarcinoma
and/or intestinal-type metaplasia be ruled out [21]. This was
eliminated by CA 125, AB-PAS and CDX-2 IHC marker
negativity within the endometrium while p63 and high mo-
lecular weight cytokeratin CK5/6 positivity in the cervix and
metastatic ovarian deposits.
Differentiation between metastatic SCC from the cervix
and primary SCC of the ovary usually has been aided by
the knowledge of the presence of a cervical tumor. Before
the diagnosis of a primary SCC of the ovary is made, the
possibility of spread from a cervical tumor, even one that
is occult should be considered unless overt features of pri-
mary neoplasia are immediately obvious. As most SCCs of
the ovary arise in the background of a pre-existing neo-
plasm such as dermoid or endometriotic cyst, thorough
sampling to identify such a component may be crucial in
determining the primary nature of the neoplasm. Al-
though the evidence strongly points to the ovarian tumor
being metastatic when both organs have been involved by
SCC, the rare association of SCC of the ovary with SCC in
situ of the cervix leaves open the possibility of independ-
ent primary neoplasms in some cases [22].
Conclusions
The ovarian involvement would have remained occult had
our patient not opted for concomitant bilateral salpingo-
oophorectomy with hysterectomy. Although the rarity of
metastatic squamous cell carcinoma to the ovaries along
with non-conventional spread of the lesion does not form a
paradigm, its propensity to remain occult with catastrophic
consequences suggests that there is a need to revisit the be-
havior of cervical SCC.Consent
Written informed consent was obtained from the patient
for publication of this Case Report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.Abbreviations
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